Literature DB >> 2528662

Characterization of a platelet derived factor modulating phagocyte functions and cooperating with interleukin 1.

E Brandt1, M Ernst, H Loppnow, H D Flad.   

Abstract

During experiments aiming at the generation of monoclonal antibodies against native human interleukin 2 an antibody of different specificity was obtained, recognizing a polypeptide contaminant within the antigen preparation used for immunization. This antigen was shown to represent a release protein from human blood platelets. Amino acid sequence analysis of the immunopurified antigen revealed its identity as beta-thromboglobulin antigen. Depending on the source of antigen (freshly lysed platelets, platelet containing cell culture supernatants) various forms of the polypeptide, differing in the degree of N-terminal truncation, were found. Beta-thromboglobulin antigen preparations differing in peptide composition also had different capacities for modulating spontaneous as well as Fc-receptor dependent chemiluminescence of human monocytes and granulocytes. In contrast to former reports, no mitogenic activity for human dermal fibroblasts was found with beta-TG antigen (CTAP III) alone, but only in combination with human interleukin 1 and heparin, the three molecules acting synergistically. These findings indicate that beta-TG antigen could play a functional role in linking the blood clotting system to the immune system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528662

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  2 in total

1.  Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.

Authors:  A Klein-Struckmeier; J Knüver-Hopf; H Mohr
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Platelet factor 4 promotes rapid replication and propagation of Dengue and Japanese encephalitis viruses.

Authors:  Amrita Ojha; Angika Bhasym; Sriparna Mukherjee; Gowtham K Annarapu; Teena Bhakuni; Irshad Akbar; Tulika Seth; Naval K Vikram; Sudhanshu Vrati; Anirban Basu; Sankar Bhattacharyya; Prasenjit Guchhait
Journal:  EBioMedicine       Date:  2018-12-05       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.